Want to see IN:FISCHER full AI Analyst Report?
FISCHER Stock Chart & Stats
₹43.67
--
Market closed
₹43.67
--
Day’s Range― - ―
52-Week Range₹31.13 - ₹124.20
Previous CloseN/A
VolumeN/A
Average Volume (3M)267.56K
Market Cap
₹23.11B
Enterprise Value₹72.00K
Total Cash (Recent Filing)₹250.46M
Total Debt (Recent Filing)₹1.07B
Price to Earnings (P/E)77.4
Beta0.33
Next Earnings
Nov 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.01%
Share Statistics
EPS (TTM)0.40
Shares Outstanding654,515,440
10 Day Avg. Volume611,655
30 Day Avg. Volume267,556
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)6.83
Price to Sales (P/S)8.52
P/FCF Ratio-20.39
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue Scale ExpansionRevenue nearly tripled in FY2026, indicating substantial scale expansion. If supported by repeatable demand, the larger base can improve operating leverage and strengthen market positioning, although the short history requires further validation.
Improved ProfitabilityThe sharp improvement from roughly 1.1% net margin in the prior year suggests better operating execution and product economics. Sustained margins would provide greater internal funding capacity and increase resilience as the business scales.
Manageable Recent LeverageRecent leverage remains moderate while equity has expanded, giving the company some balance-sheet capacity to support operations and investment. This provides a financial buffer, although historical capital weakness means execution remains important.
Bears Say
Persistent Cash BurnDeeply negative operating and free cash flow despite accounting profitability indicates weak cash conversion, working-capital intensity, or substantial reinvestment needs. Continued burn could increase reliance on external funding and constrain sustainable growth.
Sharp Debt IncreaseThe large increase in debt materially changes the company’s funding profile and raises refinancing and execution risk. Even with manageable recent debt-to-equity, higher obligations could pressure future cash flows if profitability or collections weaken.
Unproven Earnings DurabilityThe latest growth and margin gains follow a highly volatile operating history, including periods of losses and no reported revenue. This weak track record makes forecasting difficult and increases the risk that FY2026 performance reflects a non-repeatable step-change.
Fischer Medical Ventures Ltd News
FISCHER FAQ
What was Fischer Medical Ventures Ltd’s price range in the past 12 months?
Fischer Medical Ventures Ltd lowest stock price was ₹31.13 and its highest was ₹124.20 in the past 12 months.
What is Fischer Medical Ventures Ltd’s market cap?
Fischer Medical Ventures Ltd’s market cap is ₹23.11B.
When is Fischer Medical Ventures Ltd’s upcoming earnings report date?
Fischer Medical Ventures Ltd’s upcoming earnings report date is Nov 12, 2026 which is in 74 days.
How were Fischer Medical Ventures Ltd’s earnings last quarter?
Fischer Medical Ventures Ltd released its earnings results on Aug 14, 2026. The company reported ₹0.058 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Fischer Medical Ventures Ltd overvalued?
According to Wall Street analysts Fischer Medical Ventures Ltd’s price is currently Overvalued.
Does Fischer Medical Ventures Ltd pay dividends?
Fischer Medical Ventures Ltd pays a Notavailable dividend of ₹0.005 which represents an annual dividend yield of 0.01%. See more information on Fischer Medical Ventures Ltd dividends here
What is Fischer Medical Ventures Ltd’s EPS estimate?
Fischer Medical Ventures Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Fischer Medical Ventures Ltd have?
Fischer Medical Ventures Ltd has 654,515,440 shares outstanding.
What happened to Fischer Medical Ventures Ltd’s price movement after its last earnings report?
Fischer Medical Ventures Ltd reported an EPS of ₹0.058 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.337%.
Which hedge fund is a major shareholder of Fischer Medical Ventures Ltd?
Currently, no hedge funds are holding shares in IN:FISCHER
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Fischer Medical Ventures Ltd
Fischer Medical Ventures Limited, established in 1993 and headquartered in Chennai, India, is a global provider of medical equipment. The company's operations encompass the manufacturing, distribution, leasing, and maintenance of a wide array of medical devices. Its comprehensive product offerings include advanced diagnostic imaging systems such as MRI and CT scanners; specialized screening tools for cancer and tuberculosis, including handheld x-ray units; and innovative solutions like spincare technology and contactless screening. The portfolio further extends to preventive health kiosks, e-health access points, various software solutions, plant-derived nutraceuticals, mental health solutions, and a range of other preventive diagnostic devices and ancillary medical instruments. The company adopted its current name, Fischer Medical Ventures Limited, in March 2024, having previously operated as Fischer Chemic Limited.
Technical Analysis
Aarti Pharmalabs Limited
―
Marksans Pharma Limited
―
Shilpa Medicare Limited
―
Strides Pharma Science Ltd
―
Thyrocare Technologies Ltd
―